GlassScriptPhysician profile
Jose A Marques
NPI 1033101068
$3,951.27
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,272 · 2020: $1,201 · 2021: $478.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $794.93 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $732.15 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $673.78 | 2019-2021 | |
| Genentech USA, INC. | $228.71 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $196.55 | 2019 | |
| Amgen INC. | $174.07 | 2019-2020 | |
| Clovis Oncology, INC. | $148.20 | 2019-2020 | |
| Abbvie INC. | $125.50 | 2019-2020 | |
| Pbg Puerto Rico LLC | $107.51 | 2019-2021 | |
| Janssen Biotech, INC. | $99.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.14 | 2020-2021 | |
| Ipsen Biopharmaceuticals, INC | $94.62 | 2019 | |
| Incyte Corporation | $94.49 | 2019 | |
| Merck Sharp & Dohme LLC | $76.65 | 2019 | |
| Eli Lilly Export S.A. Puerto Rico Branch | $62.40 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $39.70 | 2019 | |
| Pfizer Pharmaceuticals LLC | $36.16 | 2019 | |
| Exelixis INC. | $35.26 | 2019-2020 | |
| Puma Biotechnology, INC. | $28.86 | 2021 | |
| Eisai INC. | $26.39 | 2019 | |
| Novartis Pharmaceuticals Corporation | $20.74 | 2019 | |
| Eusa Pharma (US) LLC | $20.41 | 2019 | |
| Genzyme Corporation | $19.90 | 2019 | |
| Seagen INC. | $18.15 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Marques listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.